The US Food and Drug Administration (FDA) has determined the shortage of tirzepatide injection, a glucagon-like peptide 1 ...
Highlights,The FDA has removed Eli Lilly’s popular weight-loss and diabetes drugs from its shortage list, reducing the market ...
The Texas attorney general sues major insulin makers over rising costs. Ghana confirms its first mpox case of the year. Eli Lilly's weight-loss drugs are removed from the FDA's shortage list as ...